Danaher Corporation $DHR Stake Raised by Fisher Asset Management LLC

Fisher Asset Management LLC increased its holdings in shares of Danaher Corporation (NYSE:DHR) by 2.0% in the third quarter, HoldingsChannel reports. The institutional investor owned 4,573,887 shares of the conglomerate’s stock after purchasing an additional 89,113 shares during the quarter. Fisher Asset Management LLC’s holdings in Danaher were worth $1,013,345,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of DHR. Eurizon Capital SGR S.p.A. lifted its holdings in Danaher by 16.8% in the third quarter. Eurizon Capital SGR S.p.A. now owns 284,412 shares of the conglomerate’s stock valued at $63,120,000 after buying an additional 41,003 shares during the period. Nan Fung Trinity HK Ltd. boosted its stake in Danaher by 150.5% in the third quarter. Nan Fung Trinity HK Ltd. now owns 171,200 shares of the conglomerate’s stock valued at $37,929,000 after acquiring an additional 102,865 shares during the last quarter. Van Strum & Towne Inc. bought a new position in Danaher in the third quarter valued at approximately $217,000. Three Bridge Wealth Advisors LLC acquired a new stake in Danaher during the 3rd quarter worth $55,000. Finally, Schwallier Wealth Management LLC acquired a new stake in Danaher during the 3rd quarter worth $229,000. 79.05% of the stock is owned by institutional investors.

Insider Buying and Selling at Danaher

In related news, EVP Gregory M. Milosevich sold 2,100 shares of the firm’s stock in a transaction on Monday, November 9th. The stock was sold at an average price of $230.62, for a total transaction of $484,302.00. Following the sale, the executive vice president owned 22,367 shares of the company’s stock, valued at approximately $5,158,277.54. This trade represents a 8.58% decrease in their position. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CAO Christopher Bouda sold 7,598 shares of Danaher stock in a transaction dated Wednesday, October 28th. The stock was sold at an average price of $234.56, for a total value of $1,782,186.88. Following the transaction, the chief accounting officer owned 9,107 shares in the company, valued at approximately $2,136,137.92. This represents a 45.48% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 10.80% of the stock is owned by insiders.

Wall Street Analyst Weigh In

DHR has been the subject of several recent research reports. Wells Fargo & Company dropped their target price on shares of Danaher from $212.00 to $195.00 and set an “equal weight” rating for the company in a research report on Wednesday, July 22nd. JPMorgan Chase & Co. raised their price target on Danaher from $250.00 to $270.00 and gave the stock an “overweight” rating in a research report on Thursday, October 22nd. Citigroup raised their price target on Danaher from $230.00 to $270.00 and gave the stock a “buy” rating in a research report on Thursday, October 22nd. TD Cowen lifted their price objective on Danaher from $255.00 to $270.00 and gave the stock a “buy” rating in a research note on Thursday, October 22nd. Finally, Stifel Nicolaus upped their price objective on Danaher from $220.00 to $260.00 and gave the company a “buy” rating in a report on Thursday, October 22nd. Eighteen investment analysts have rated the stock with a Buy rating and five have issued a Hold rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus price target of $242.91.

Danaher Stock Down 1.4%

Danaher stock opened at $232.08 on Friday. The company’s 50 day simple moving average is $222.11 and its 200 day simple moving average is $201.53. Danaher Corporation has a fifty-two week low of $160.93 and a fifty-two week high of $242.80. The firm has a market capitalization of $163.28 billion, a price-to-earnings ratio of 37.98, a PEG ratio of 2.95 and a beta of 0.76. The company has a debt-to-equity ratio of 0.45, a current ratio of 1.63 and a quick ratio of 1.29.

Danaher (NYSE:DHR) last issued its quarterly earnings data on Wednesday, October 21st. The conglomerate reported $2.11 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.92 by $0.19. Danaher had a net margin of 16.91% and a return on equity of 11.17%. The firm had revenue of $6.55 billion during the quarter, compared to analysts’ expectations of $6.56 billion. During the same quarter in the previous year, the company earned $1.89 earnings per share. The business’s revenue for the quarter was up 8.3% on a year-over-year basis. As a group, sell-side analysts anticipate that Danaher Corporation will post 8.59 EPS for the current year.

Danaher Dividend Announcement

The company also recently declared a quarterly dividend, which was paid on Friday, October 30th. Stockholders of record on Wednesday, September 30th were given a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date of this dividend was Wednesday, September 30th. Danaher’s dividend payout ratio (DPR) is currently 26.19%.

Danaher Company Profile

Danaher is a global science and technology company that develops and supplies products and services for biotechnology, life sciences, and diagnostics markets. Its offerings include instruments, reagents, consumables, software, and services used in research, drug development and manufacturing, and clinical testing. The company’s businesses include well-known brands such as Cytiva and Pall in bioprocessing and filtration, Beckman Coulter in laboratory and clinical diagnostics, Cepheid in molecular diagnostics, and Leica Microsystems in microscopy.